Background: Millions of people worldwide have been affected by the COVID-19 pandemic. Due to the prevalence of malnutrition, refusal of immunization during a pandemic, nutritional anemia, air pollution, poverty, poor parental education, inadequate access to high-quality acute healthcare, the clinical characteristics and outcomes of children in Bangladesh may vary from other countries. Information on clinical presentations, outcomes, the relationship between disease incidence and the prevalence of associated disease in Bangladeshi children affected by COVID-19 are scarce. Objective: In this study, our main goal was to evaluate the clinical profile of pediatric COVID-19 patients in child corona unit of Dhaka Medical College Hospital, Bangladesh. Method: This single center observational study was conducted in Child Corona Unit of Dhaka Medical College Hospital (DMCH). A total of 1020 COVID-19 positive pediatric patients were included in this study. Results: In our study, 89.1% of patients had fever, 80.8% had a cough, 23.1% had diarrhea, and 70.8% had myalgia. According to CXR reports, 2.1% patients had ground-glass opacity, 38% had local patchy shadowing, 31.8% patients had bilateral patchy shadowing and 27.9% patients had interstitial abnormalities. Correlation of disease severity between without co-morbidity and with co-morbidity is statistically significant (p=0.01). Conclusion: This research revealed a variable range of presentations. This sheds light on the cases of COVID-19 in the pediatric population. Children with COVID-19 normally present with or are asymptomatic with different symptoms; infants may have a high risk of serious illness. However, most cases were reported in children 11-15 years of age and fever, cough, nasal congestion and dyspnoea were typical symptoms. Serious cases were those with co-morbidity and in order to save them additional attention during home care and prompt hospitalization therapy are needed.
Objective: The present study was undertaken to assess liver function (using markers like SGPT, serum bilirubin, prothrombin time, serum albumin) in children suffering from Acute Lymphoblastic Leukemia. Materials & Methods: This study was carried out in the Department of Pediatric Hematology & Oncology, Dhaka Medical College Hospital, Dhaka, over a period 12 months from the day of approval of the protocol. All acute lymphoblastic leukaemia children admitted in Pediatric Hematology & Oncology Department in Dhaka Medical College Hospital and receiving chemotherapy of standard protocol for induction of remission were the study population. A total of outcome variable was hepatotoxicity resulting from chemotherapy given for induction of remission. Result: The mean age of the children was 4.4 years (range 2- 8 years). Males were a bit higher in the series with male to female ratio being 11:9. Liver function tests before therapy revealed that none of the children exhibited raised serum billirubin and only 2(4.5%) children had increased SGPT. However, 50% of the children had raised prothrombin and 43.2% had reduced serum . albumin. Liver function tests after therapy after induction of remission shows that 9(20.5%) children exhibited raised serum billirubin, the proportion of children with raised prothrombin remained almost same as before but the status of serum billirubin improved to some extent. However, proportion of children with raised SGPT was increased to 25%. Comparison of liver function in children after therapy during induction of remission with that before induction did not show any significant difference, except that the serum SGPT was significantly raised during induction of remission (p < 0.001). Conclusion: The study concluded that the current therapy for induction of remission of ALL cases does not produce any toxic effect on liver. Although, enzymes like SGPT take a sharp rise during induction of remission, it is transient and does produce any deleterious effect on liver. J Dhaka Medical College, Vol. 29, No.1, April, 2020, Page 33-37
Background: Platelet indices (plateletcrit, mean platelet volume, platelet distribution width and Platelet count) are potentially useful markers for the early diagnosis and outcome of many diseases. Platelet indices could serve as surrogate marker for remission in patients with ALL. Objective: To observe change of platelet indices in ALL during induction of remission. Material & Methods: This observational study was carried out with 52 newly diagnosed ALL patients ranging from 1.5 to 12 years admitted at DMCH, from January to December 2015. Platelet indices such as plateletcrit (PCT), mean platelet volume (MPV), platelet distribution width (PDW) and platelet count (PLT) were monitored from admission to induction of remission phase of chemotherapy and were analyzed. Result: Mean PLT was found 93442.3±29966.4 cmm before treatment, 137442.3±27217.9 cmm in 1st week and 231653.8±42543.5 cmm in 4th week. Mean PCT was found 0.09±0.11% before treatment, 0.16±0.11% in 1st week and 0.25±0.18 % in 4th week. Both PLT & PCT was increased significantly during induction of remission after one and four weeks. Mean PDW was found 13.1±3.9 fl before treatment, 12.9±3.5 fl in 1st week and 12.0±3.1 fl in 4th week. MPV was found 10.6±2.1 fl before treatment, 11.0±1.4 fl in 1st week and 10.7±1.4 fl in 4th week. The change of MPV & PDW were not statistically significant when compared with that of before treatment. Conclusion: It can be concluded that among four important platelet indices, PLT and PCT were significantly associated with remission in ALL during induction of remission. Bangladesh J Child Health 2020; VOL 44 (1) :34-39
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.